Pharma Focus Asia

Webinar Sponsored by siemens

how manufacturing software enabling pharma companies accelerate development production

Going paperless: How the use of manufacturing software is enabling pharma companies like BioNTech to accelerate development and production

Paperless manufacturing is a big step for pharma companies. Manufacturers are continuously looking for innovative ways to accelerate new and existing plants and processes.

Faced with the challenge of repurposing a vaccine plant in record time, BioNTech needed a proven and scalable MES software solution to guide and control CovId-19 vaccine production for their plant in Marburg, Germany.

This webinar will introduce the key concepts of paperless manufacturing that were deployed by BioNTech, from the design of the batch record, integration to the automated plant and to the release of the batch report.


  • Quality
  • Production
  • IT
  • Engineering
  • Automation
  • Integrators
  • Consultants

In this webinar you will learn:

  • Learn how paperless manufacturing and electronic batch recording is being deployed in the pharma industry today, with a focus on the BioNTech case study.
  • Get to know the key concepts and benefits of electronic batch recording through design, execution, integration to automation and review by exception.
  • Discover innovative ways of implementing MES solutions using modular solutions, cloud-based architecture, and pharma ready apps.

Register for free to get video access

Andrew Whytock

Andrew Whytock

Head of Digitalization, Pharma Segment, Siemens

About - Andrew Whytock

Andrew works in the Siemens Pharma Competence Center in Karlsruhe, Germany where he has global responsibility for digitalization initiatives in the pharmaceutical industry. With more than 20 years in the software industry, in a variety of consultative and business development roles around Europe, Andrew has been involved in industrial software and digitalization in biopharma for the last 10 years. His principal focus is to lead different innovation initiatives, providing insight to pharma on Industry 4.0 and digitalization, facilitating the transition towards the digital pharma enterprise.